Author: Ravi Shankar

Separate 6 GWh expansion planned by year-end 2026 would more than double the existing Nanjing facility’s annual cell capacity

DALIAN, China, Sept. 23, 2026 (GLOBE NEWSWIRE) — CBAK Energy Technology Limited (NASDAQ: CBAT) (“CBAK Energy” or the “Company”), a China-based lithium-ion battery manufacturer and energy solutions provider, today announced that it has signed an investment agreement with the Nanjing Gaochun Economic Development Zone for the research, development and manufacture of large cylindrical sodium-ion battery cells and integrated battery systems in Nanjing, Jiangsu Province. The project would add 12 gigawatt-hours (“GWh”) of annual cell production capacity, advancing the Company’s previously announced sodium-ion expansion plan.

CBAK Energy advances its sodium-ion expansion with a planned 12 GWh project in Nanjing.

Separately, CBAK Energy targets an additional 6 GWh of annual cell capacity at its existing Nanjing facility by year-end 2026. The Company plans to advance the 12 GWh project in the second half of 2027, subject to securing financing.

6 GWh Expansion at the Existing Nanjing Facility
To meet strong demand for Model 60150 large cylindrical cells, CBAK Energy plans to expand its existing Nanjing facility in the second half of 2026. The facility currently has 4.5 GWh of annual Model 32140 cell capacity. The additional 6 GWh would bring its total annual cell capacity to 10.5 GWh.

At full capacity with all output sold, the additional 6 GWh could generate an estimated RMB2.4 billion to RMB2.7 billion (approximately US$356 million to US$400 million) in annual revenue.

The Company is considering two Model 60150 production lines for the expansion. Given strong demand for Model 32140 cells, it may instead install one Model 32140 line and one Model 60150 line. The cell models and production-line configuration may be adjusted as market conditions and customer demand evolve.

12 GWh Project to Support Sodium-Ion and Lithium-Ion Production
The production lines will be designed to manufacture large cylindrical sodium-ion or lithium-ion cells. The Company will determine which chemistry to produce based on market conditions and customer demand. At current lithium-ion cell market prices, the Company estimates that the 12 GWh project could generate an additional RMB4.8 billion to RMB5.0 billion (approximately US$712 million to US$741 million) in annual revenue at full capacity with all output sold.

The project would cover cell manufacturing as well as module and battery pack integration. Development would proceed in phases based on financing, customer demand and project readiness.

Customer testing of CBAK Energy’s sodium-ion cell samples is underway in residential and portable energy storage and electric mobility applications. Additional evaluations cover specialty vehicles, start-stop systems and backup power.

“The 6 GWh expansion would more than double annual cell capacity at our existing Nanjing facility and help us meet strong demand for large cylindrical cells,” said Zhiguang Hu, Chief Executive Officer of CBAK Energy. “The 12 GWh investment agreement advances our plans for sodium-ion production. Designing the lines to produce lithium-ion cells as well would give us more options to serve customers as demand develops in both markets. We plan to develop the project in phases, with investment guided by financing availability and customer demand.”

About CBAK Energy
CBAK Energy Technology Limited (NASDAQ: CBAT) is a China-based company that develops, manufactures and sells high-power lithium-ion and sodium-ion batteries, as well as materials used in high-power lithium-ion batteries. It has battery cell production, research and development, and sales operations in Nanjing, Dalian and Shangqiu, with research and development centers in Nanjing and Dalian. Its raw materials business is based in Shaoxing. The Company’s products serve electric vehicles, light electric vehicles, energy storage systems and other high-power applications. In January 2006, CBAK Energy became the first Chinese lithium battery manufacturer to be listed on the Nasdaq Stock Market.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.

These statements include expectations about the planned 12 GWh large cylindrical battery cell and integrated battery systems project; phased development and plans to advance the project in the second half of 2027, subject to financing; the ability of the planned lines to produce sodium-ion or lithium-ion cells and the choice of chemistry based on market conditions; customer testing, qualification and commercial adoption; the separate 6 GWh Nanjing expansion and targeted increase in annual capacity at the existing facility to 10.5 GWh by year-end 2026; future demand for Model 60150 and Model 32140 cells, potential production-line configurations and changes in cell models; estimated additional annual revenue from each project; and the Company’s growth prospects.

Words such as “expect,” “estimate,” “anticipate,” “believe,” “intend,” “plan,” “target,” “may,” “will,” “would” and “could,” and similar expressions, identify forward-looking statements. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially.

Risks include changes in customer demand, product requirements, market prices and order volumes; the timing and outcome of customer testing and qualification and whether they lead to commercial orders; the availability, timing and cost of financing; the availability and cost of raw materials, production equipment and other inputs; technology development and market acceptance of sodium-ion batteries; delays in construction, equipment installation, commissioning or production ramp-up; manufacturing yields, capacity utilization, product quality and operating efficiency; the ability of the planned lines to support both sodium-ion and lithium-ion production; changes in cell models, production-line configuration and the choice of chemistry; regulatory, environmental and other required approvals; foreign exchange fluctuations; competing battery technologies; and other risks described in the Company’s reports filed with or furnished to the U.S. Securities and Exchange Commission.

The revenue estimates assume a full year of operation at full capacity with all output sold and are not guidance for a particular reporting period. The 12 GWh estimate uses current lithium-ion cell market prices as a benchmark. Neither estimate represents contracted sales. Actual revenue will depend on project completion, customer qualification, product mix, market pricing, utilization, manufacturing yields and sales, and may differ materially from these estimates.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements as a result of new information, future events or otherwise.

For more information, please visit: https://en.cbak.com.cn/
Email: marketing@cbak.com.cn
LinkedIn: https://www.linkedin.com/company/cbakenergy
X: https://x.com/CBAKEnergy
Stocktwits: https://stocktwits.com/CBAK_Energy

Investor Relations
Email: ir@cbak.com.cn
Website: https://ir.cbak.com.cn/

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3bb20fc1-b036-4233-a3f2-e3d945e5c98c

Expansion Into Vintage Eyewear and Furniture Broadens Revenue Opportunities and Supports the Company’s Long-Term Growth Strategy

CHEYENNE, Wyo., Sept. 23, 2026 (GLOBE NEWSWIRE) — TransGlobal Assets Inc. (OTCID: TMSH) today announced that its wholly owned subsidiary, M Love Vintage Holdings Inc., is expanding beyond vintage clothing into vintage eyewear and vintage furniture, representing the next step in the Company’s strategy to build a diversified vintage lifestyle platform.

Management believes the expansion broadens the Company’s addressable market while creating opportunities to develop multiple revenue channels across fashion, accessories, home décor, wholesale distribution, e-commerce, and international sales.

Riding the Growth of the Global Resale Economy

The expansion comes as the global resale market continues to experience significant growth.

According to ThredUp’s 2026 Resale Report, prepared in partnership with GlobalData, the global secondhand apparel market is projected to reach approximately $393 billion by 2030, growing twice as fast as the overall apparel market. The report also projects that Gen Z and Millennials will account for more than 70% of future market growth.

Management believes these trends reflect continued consumer interest in sustainability, affordability, individuality, and authentic, one-of-a-kind products.

By adding vintage eyewear and furniture to its offerings, M Love Vintage is expanding its participation in the broader vintage and resale marketplace while pursuing opportunities across multiple consumer categories.

Building Multiple Revenue Channels

The Company’s evolving platform is expected to include:

• Vintage Clothing

• Vintage Eyewear

• Vintage Furniture

• Collectible Home Décor

• Online Retail

• Wholesale Distribution

• International Sales

Management believes that expanding into complementary product categories may increase customer engagement, encourage repeat purchases, diversify potential revenue sources, and leverage the Company’s existing sourcing and merchandising capabilities.

Christopher Villareale, President of TransGlobal Assets Inc., stated:

“This expansion represents another important milestone in building M Love Vintage into more than a vintage clothing business. By broadening into eyewear and furniture, we’re creating opportunities to serve a larger customer base while expanding our long-term growth potential. We believe this strategy strengthens our brand and positions the Company to participate in one of retail’s fastest-growing segments.”

More to Come

Today’s announcement represents one component of the Company’s broader strategic growth plan.

Management is actively advancing additional initiatives across its operating businesses and looks forward to providing shareholders with further updates as these developments progress.

About TransGlobal Assets Inc. (OTCID: TMSH)

TransGlobal Assets Inc. is a Wyoming corporation focused on strategic acquisitions, corporate restructuring, and the development of emerging business opportunities. The Company continues to evaluate transactions aligned with its long-term strategic objectives and shareholder value.

About M Love Vintage

M Love Vintage Holdings Inc. is a wholly owned subsidiary of TransGlobal Assets Inc. focused on the vintage lifestyle marketplace, including vintage clothing, eyewear, furniture, collectibles, and related products.

Website: mlovesvintageholdings.com

X: M Loves Vintage (@mlovesvintage1) / X

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, among other things, statements regarding the Company’s business strategy, expansion plans, potential revenue opportunities, market opportunities, growth potential, and future initiatives. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.

Contact

TransGlobal Assets Inc. (OTCID: TMSH)
310-228-8897
Investor Relations
reino@mlovesvintageholdings.com

Hong Kong, Sept. 23, 2026 (GLOBE NEWSWIRE) — Green Circle Decarbonize Technology Limited (the “Company”) (NYSE American: GCDT), a Cayman Islands holding company that, through its Hong Kong subsidiary, Boca International Limited, develops and manufactures Phase Change Material (PCM-TES) storage systems designed for cooling and heating applications, today announced that it will effect a 1-for-6 share consolidation (“Share Consolidation”) of its ordinary shares, including its class A ordinary shares, par value US$0.001 per share (“Class A Ordinary Shares”).

The Share Consolidation was approved by the Company’s board of directors and subsequently approved by the Company’s shareholders at an Extraordinary General Meeting held on August 10, 2026.

Share Consolidation

The Share Consolidation will combine every six (6) issued and unissued shares of the Company’s authorized share capital into one (1) share, with the par value of each share increasing from US$0.001 to US$0.006. The Share Consolidation will become effective at 12:01 a.m. Eastern Time on Wednesday, October 7, 2026.

The Company’s Class A Ordinary Shares are expected to commence trading on a split-adjusted basis at the opening of trading on the NYSE American on Wednesday, October 7, 2026, subject to applicable NYSE American procedures.

The Company’s Class A Ordinary Shares will continue to trade on the NYSE American under the Company’s existing trading symbol, “GCDT.” The new CUSIP number for the Class A Ordinary Shares following the Share Consolidation will be G4092C131.

The Share Consolidation will proportionately reduce the number of issued and outstanding Class A Ordinary Shares. The Company’s authorized share capital will also be adjusted to reflect the Share Consolidation in accordance with the Company’s amended and restated memorandum and articles of association.

No fractional shares will be issued as a result of the Share Consolidation. Any fractional share entitlement resulting from the Share Consolidation will be rounded up to the next whole share in accordance with the shareholder resolution approving the Share Consolidation.

The 1-for-6 Share Consolidation will automatically combine six (6) existing Class A Ordinary Shares into one (1) new Class A Ordinary Share. The Company’s transfer agent, Odyssey Trust Company, will serve as transfer and exchange agent in connection with the Share Consolidation.

Registered shareholders holding pre-consolidation Class A Ordinary Shares electronically in book-entry form will not be required to take any action to receive their post-consolidation shares. Shareholders holding Class A Ordinary Shares through a broker, bank, trust company or other nominee will have their positions automatically adjusted to reflect the Share Consolidation, subject to the particular procedures of their broker, bank or nominee, and will not be required to take any action in connection with the Share Consolidation.

Holders of physical share certificates should contact Odyssey Trust Company for instructions regarding the exchange of certificates for post-consolidation shares.

Additional Information

Each outstanding stock option, warrant, restricted share unit or other security convertible into or exercisable for the Company’s ordinary shares that remains outstanding immediately prior to the effective time of the Share Consolidation will, as applicable, be adjusted in accordance with the terms of the applicable instrument, agreement or plan to reflect the 1-for-6 Share Consolidation.

The Share Consolidation will increase the par value of the Company’s shares from US$0.001 to US$0.006 per share and will result in a corresponding adjustment to the Company’s authorized share capital.

The primary purpose of the Share Consolidation is to increase the per-share trading price of the Company’s Class A Ordinary Shares and support the Company’s continued compliance with the NYSE American’s continued listing requirements.

About Green Circle Decarbonize Technology Limited

Green Circle Decarbonize Technology Limited is a Cayman Islands holding company operating through its Hong Kong subsidiary, Boca International Limited. The Company is a provider of advanced energy saving solutions supported by proprietary phase change thermal energy storage materials and thermal engineering services.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “aim”, “anticipate”, “believe”, “estimate”, “expect”, “going forward”, “intend”, “may”, “plan”, “potential”, “predict”, “propose”, “seek”, “should”, “will”, “would” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.

For more information, please contact:

Green Circle Decarbonize Technology Limited

Chief Financial Officer
Email: louis.leung@vbg.com.hk

Company Intends to Use Proceeds to Acquire SOL

AUSTIN, TX, Sept. 23, 2026 (GLOBE NEWSWIRE) — Forward Industries, Inc. (NASDAQ: FWDI) (the “Company” or “Forward”), the leading Solana treasury company, today announced that it has entered into a securities purchase agreement with an institutional investor for the purchase and sale of 3,125,000 shares of the Company’s common stock at a price of $8.00 per share.

Aggregate gross proceeds are expected to be approximately $25 million, before fees and deducting placement agent fees and other estimated offering expenses. The offering is expected to close on or about September 24, 2026, subject to customary closing conditions. Forward intends to use the net proceeds to acquire additional SOL to grow the absolute size of its SOL treasury while the Company increases SOL per fully diluted share.

A.G.P./Alliance Global Partners is acting as sole placement agent for the offering.

The shares are being offered pursuant to the Company’s effective shelf registration statement on Form S-3ASR (File No. 333-290312), which was declared effective by the Securities and Exchange Commission (“SEC”) on September 17, 2025. A prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Additionally, when available, electronic copies of the prospectus supplement and the accompanying prospectus may be obtained from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@allianceg.com.

About Forward Industries, Inc.

Forward Industries, Inc. (NASDAQ: FWDI) is a Solana focused digital asset treasury company, with the strategy to buy, hold, stake, trade, invest in, and grow SOL and SOL related digital assets, protocols and businesses. Forward’s mission is to expand and strengthen the Solana ecosystem by acquiring and staking SOL and engaging with, providing tools to and investing in the Solana network, Solana developers and Solana related projects in order to increase shareholder value. In connection with a private placement transaction in September 2025, Forward launched a digital asset treasury strategy supported by industry leading investors and operating partners including Galaxy Digital and Jump Crypto. For more information on the Company’s Solana treasury strategy, visit www.forwardindustries.com.

Forward Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “project,” and other words of similar meaning. These forward-looking statements address various matters including statements relating to the anticipated use of proceeds from the offering, the expected closing date of the offering, the expected impact of the offering on SOL per share, the Company’s plan for value creation and strategic advantages, and market size and growth opportunities. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others: failure to realize the anticipated benefits of the digital asset treasury strategy; changes in business, market, financial, political, and regulatory conditions; risks relating to the Company’s operations and business, including the highly volatile nature of the price of Solana and other cryptocurrencies and the incurrence of indebtedness; the risk that the price of the Company’s common stock may be highly correlated to the price of the digital assets that it holds; risks related to the performance and expected return of the companies and projects that the Company has invested in; risks related to increased competition in the industries and markets in which the Company does and will operate (including the applicable digital assets market); risks relating to significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally; risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; as well as those risks and uncertainties identified in the Company’s filings with the Securities and Exchange Commission. The forward-looking statements in this press release speak only as of the date of this document, and the Company undertakes no obligation to update or revise any of these statements. Investors should not place undue reliance on forward-looking statements.

Contacts
Media Contact
comms@forwardindustries.com

Investor Relations Contact
Sean Mansouri, CFA / Aaron D’Souza
Elevate IR
(720) 330-2829
ir@forwardindustries.com

As part of the implementation of Bang & Olufsen A/S’ long-term share-based incentive programs certain members of management have acquired shares in Bang & Olufsen A/S vested under the programs. In that connection, Bang & Olufsen A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in Bang & Olufsen made by persons discharging managerial responsibilities in Bang & Olufsen A/S and/or persons closely related with them.

Please see attached file for details.

For further information, please contact: Sr. Director, Strategy & Investor Relations, Cristina Rønde Hefting, phone: +45 4153 7303.

Attachment

• BO_2618_PDMR Announcement (vesting of shares)_Nikolaj Wendelboe

InstaMortgage reported approximately $4.5 million in revenue and $3.3 million in gross profit for the six months ended June 30, 2026, while reporting positive net income

Unaudited pro forma combined revenue was approximately $6.4 million for the six months ended June 30, 2026, and approximately $11.8 million for the year ended December 31, 2025

DUBLIN, Ohio, Sept. 23, 2026 (GLOBE NEWSWIRE) — reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), an AI-powered real estate technology company, today announced financial and operating results for InstaMortgage Inc. (“InstaMortgage”) and unaudited pro forma combined financial information following the completion of its acquisition of InstaMortgage.

InstaMortgage Standalone Financial Performance

InstaMortgage was acquired by reAlpha with an established operating business that generated revenue, gross profit and positive net income in 2025, while remaining profitable through the second quarter of 2026.

For the year ended December 31, 2025, InstaMortgage:

• Generated approximately $7.3 million in revenue;
• Generated approximately $5.3 million in gross profit;
• Reported approximately $0.1 million in net income; and
• Originated approximately $277.1 million in residential mortgage loan volume.

For the six months ended June 30, 2026, InstaMortgage:

• Generated approximately $4.5 million in revenue;
• Generated approximately $3.3 million in gross profit;
• Reported approximately $0.2 million in net income; and
• Originated approximately $177.0 million in residential mortgage loan volume.

As of June 30, 2026, InstaMortgage has originated more than $3.5 billion in residential mortgage loans since 2015, supported by a full-cycle lending operation spanning origination, underwriting, funding and loan sale.

“We believe that InstaMortgage meaningfully strengthens reAlpha’s financial and operating foundation and demonstrates what we are looking to build through our acquisition strategy,” said Thomas Kutzman, Chief Financial Officer of reAlpha. “On a pro forma basis, the acquisition increases our 2025 revenue by approximately 162% and gross profit by approximately 215%, while adding a direct-lending business that generated positive net income in 2025 while remaining profitable through the first six months of 2026. We are adding scale, but we are also adding capabilities and transaction economics that fit directly into the platform we have been building.”

Kutzman continued, “We are now operating at a larger scale, with a broader base of loan officers, which we believe provide opportunities to identify potential operational synergies and cost efficiencies over time. The expansion in the number of states in which we offer both real estate and mortgage services could create opportunities for revenue synergies by serving customers in these markets with multiple services over the course of a given transaction.”

Unaudited Pro Forma Combined Financial Information

For the six months ended June 30, 2026, reAlpha and InstaMortgage would have had approximately $6.4 million in unaudited pro forma combined revenue and approximately $4.6 million in unaudited pro forma combined gross profit.

For comparison, reAlpha reported approximately $2.0 million in standalone revenue and approximately $1.3 million in standalone gross profit for the same six-month period.

For the year ended December 31, 2025, reAlpha and InstaMortgage would have had approximately $11.8 million in unaudited pro forma combined revenue and approximately $7.7 million in unaudited pro forma combined gross profit.

For comparison, reAlpha reported approximately $4.5 million in standalone revenue and approximately $2.5 million in standalone gross profit for fiscal 2025. Accordingly, the unaudited pro forma combined figures represent approximately 2.6 times reAlpha’s reported standalone revenue and 3.2 times its reported standalone gross profit for the period.

The unaudited pro forma combined financial information was prepared in accordance with Article 11 of Regulation S-X. For purposes of the statements of operations, the financial information gives effect to the acquisition as if it had occurred on January 1, 2025 and is presented for informational purposes only.

The unaudited pro forma financial information is not necessarily indicative of consolidated results of operations of the combined business had the acquisition occurred at the beginning of the respective period, nor is it necessarily indicative of future results of operations of the combined company. The unaudited pro forma financial information is based on various assumptions and estimates and should be read in conjunction with the full set of pro forma financial information and the accompanying notes, as presented in Amendment No.1 to the Company’s Current Report on Form 8-K/A that will be filed with the Securities and Exchange Commission (the “SEC”) on September 23, 2026.

About reAlpha Tech Corp.

reAlpha Tech Corp. (Nasdaq: AIRE) is an AI-powered real estate technology company that aims to transform the multi-trillion-dollar U.S. real estate services market. reAlpha is developing an end-to-end platform that streamlines real estate transactions through integrated brokerage, mortgage, and title services. With a strategic, acquisition-driven growth model and proprietary AI infrastructure, reAlpha is building a vertically integrated ecosystem designed to deliver a simpler, smarter, and more affordable path to homeownership. For more information, visit www.realpha.com.

About InstaMortgage Inc.

Originally founded in 2008 by Shashank Shekhar as Arcus Lending, the company rebranded as InstaMortgage, NMLS 1035734, in 2021. InstaMortgage aims to provide a different mortgage experience to its clients across 29 states and Washington D.C. By combining technology with expert advice, excellent customer service, and competitive rates, InstaMortgage delivers mortgage options that are tailored to each client’s unique financial situation. To learn more, visit www.instamortgage.com.

Forward-Looking Statements        

The information in this press release includes “forward-looking statements.” Any statements other than statements of historical fact contained herein, including statements by reAlpha’s Chief Financial Officer, Thomas Kutzman, or statements about the InstaMortgage acquisition, the anticipated benefits of the InstaMortgage acquisition, reAlpha’s ability to integrate InstaMortgage into its business and scale its business following the acquisition of InstaMortgage, reAlpha’s long-term platform strategy and anticipated benefits to customers, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “could”, “might”, “plan”, “possible”, “project”, “strive”, “budget”, “forecast”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: reAlpha and InstaMortgage’s ability to obtain regulatory approval in Virginia and New York; reAlpha’s ability to realize the expected benefits of the acquisition of InstaMortgage and its operations, including the possibility that the expected benefits from the acquisition will not be realized or will not be realized within the expected time period; the potential negative effects of the Company’s and InstaMortgage’s business from not obtaining the regulatory approvals in Virginia and New York timely or at all; the health of the U.S. residential real estate industry and changes in general economic conditions; reAlpha’s ability to pay contractual obligations, including with respect to the acquisition of InstaMortgage; reAlpha’s liquidity, operating performance, cash flow and ability to secure adequate financing; reAlpha’s ability to maintain compliance with Nasdaq’s continued listing rules; reAlpha’s ability to generate additional sales or revenue from having access to, or obtaining, additional U.S. states brokerage licenses; whether reAlpha’s technology and products will be accepted and adopted by its customers and intended users; reAlpha’s ability to integrate the business of its acquired companies into its existing business, including InstaMortgage, and the anticipated demand for such acquired companies’ services; reAlpha’s ability to successfully enter new geographic markets and to scale its operational capabilities to expand into additional geographic markets and nationally; the potential loss of key employees of reAlpha and of its subsidiaries; reAlpha’s ability to obtain, and maintain, the required licenses to operate in the U.S. states in which it, or its subsidiaries, operate in, or intend to operate in; reAlpha’s ability to maintain and strengthen its brand and reputation; reAlpha’s ability to continue attracting loan officers and maintain its relationship with its REALTOR® affiliate to expand its operations nationally; the availability of rebates, which may be limited or restricted by state law; risks related to data privacy, including evolving laws and consumer expectations; the inability to accurately forecast demand for AI-based real estate-focused products; the inability to execute business objectives and growth strategies successfully or sustain reAlpha’s growth; the inability of reAlpha’s customers to pay for reAlpha’s services; reAlpha’s ability to obtain additional financing or access the capital markets on acceptable terms and conditions in the future; changes in applicable laws or regulations, including with respect to the real estate market, AI and AI technologies, and the impact of the regulatory environment and complexities with compliance related to such environment; reAlpha’s ability to effectively compete in the real estate and AI industries; and other risks and uncertainties indicated in reAlpha’s most recent Annual report on Form 10-K and current or periodic reports filed with the SEC and available for review at www.sec.gov. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements. Although reAlpha believes that the expectations reflected in the forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. reAlpha’s future results, level of activity, performance or achievements may differ materially from those contemplated, expressed or implied by the forward-looking statements, and there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking statements. For more information about the factors that could cause such differences, please refer to reAlpha’s filings with the SEC. Readers are cautioned not to put undue reliance on forward-looking statements, and reAlpha does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Media Contact:

Payton Cuddy, Senior Marketing Manager
media@realpha.com

Investor Relations Contact:

Adele Carey, VP of Investor Relations
InvestorRelations@reAlpha.com

VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing technologies, is pleased to announce the deployment of its BreathLogix alcohol screening solution at a manufacturing facility located in Alabama. The deployment marks the first delivery of the BreathLogix solution to a U.S.-based manufacturing company.

The deployment supports the customer’s workplace safety and impairment prevention program by providing automated alcohol screening for employees in safety-sensitive work environments. The customer is a leading industrial printing and manufacturing organization serving businesses across North America.

BreathLogix will be used to facilitate routine employee alcohol screening as part of the facility’s safety and compliance initiatives. The system is designed to help employers identify alcohol-related impairment risks, strengthen workplace safety protocols, and support a safe working environment for employees, contractors, and visitors. The deployment is being facilitated by AlcoPro, Inc., an authorized reseller (alcopro.com).

BreathLogix rapidly screens for alcohol using a breath sample while simultaneously capturing a photograph of the user for identity verification. The system provides precise Blood Alcohol Content (BAC / BrAC) readings and can automatically deliver alerts via SMS and email to designated managers when positive results are detected.

The deployment reflects first delivery of the BreathLogix solution with a manufacturing company in the U.S. BreathLogix can meet the needs of employers seeking modern, automated screening technologies that can improve operational efficiency while supporting occupational health and safety objectives. Manufacturing facilities, logistics operations, transportation organizations, and other safety-sensitive workplaces are increasingly adopting alcohol screening programs as part of broader workforce risk management strategies.

“This deployment demonstrates the expanding application of BreathLogix within industrial and manufacturing environments,” stated Rav Mlait, Chief Executive Officer of Cannabix Technologies. “Employers continue to seek practical tools that can help reduce impairment-related risks, improve workplace safety, and support compliance with corporate safety policies. BreathLogix is designed to provide a simple and efficient screening solution that helps organizations proactively manage these challenges.”

Figure 1. BreathLogix Alcohol Screening Device Image

BreathLogix supports a broad range of alcohol screening applications, including:

• Workplace and safety-sensitive employee screening
• Manufacturing and industrial operations
• Transportation and logistics workforces
• Return-to-work and fitness-for-duty assessments
• Contractor and visitor screening programs
• Construction and infrastructure projects
• Random and scheduled alcohol testing
• Corporate health and safety initiatives

By enabling reliable and automated alcohol screening, BreathLogix helps organizations strengthen workplace safety programs, reduce impairment-related risks, improve compliance oversight, and promote a culture of accountability.

About Cannabix Technologies Inc.

Cannabix Technologies Inc. is a leading developer of breath-based technologies designed to enhance public safety and reduce impairment-related risks in a range of different settings. The Marijuana Breath Test (MBT) targets delta-9 THC—the primary psychoactive compound in cannabis—in breath, providing a practical solution for identifying recent marijuana use.

The BreathLogix, unmanned alcohol screening solution supports organizations in proactively monitoring alcohol impairment, strengthening safety protocols, and promoting responsible behavior. By delivering innovative, non-invasive screening tools, Cannabix aims to help reduce accidents, improve decision-making, and protect organizations, individuals and the public at large. Visit www.cannabixtechnologies.com

We seek Safe Harbor.  
 On behalf of the Board of Directors

“Rav Mlait”

CEO
Cannabix Technologies Inc.

For further information, contact the Company at info@cannabixtechnologies.com

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward-Looking Statements

This news release contains certain “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are often identified by words such as “expects,” “anticipates,” “believes,” “intends,” “plans,” “may,” “will,” “could,” “should,” “potential,” and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements regarding: the anticipated benefits, capabilities, reliability, performance and adoption of the Company’s BreathLogix alcohol screening solution; the expected use of BreathLogix by manufacturing companies, industrial employers, transportation organizations and other safety-sensitive workplaces; the Company’s ability to expand commercial deployments of BreathLogix in the United States and other jurisdictions; the potential for recurring revenue from product sales, service agreements, software offerings and related programs; the commercialization, market acceptance and adoption of the Company’s technologies; the Company’s ability to enter into additional customer, reseller, distribution, service or strategic partnership agreements; and the Company’s ongoing business, product development, regulatory, operational and financing plans. Forward-looking statements are based on management’s current expectations, assumptions and beliefs and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements. Such factors include, without limitation: the ability of the Company to successfully manufacture, deploy, support and maintain its technologies; customer acceptance, utilization and retention; the ability to secure additional commercial customers and distribution relationships; regulatory developments; changes in workplace safety, employment or privacy laws; competitive developments; technological advancements by competitors; economic, industry and market conditions; supply chain disruptions; the availability of financing; and other risks detailed from time to time in the Company’s public disclosure documents. There can be no assurance that the Company’s products will achieve widespread commercial acceptance, that existing deployments will result in additional contracts, recurring revenues or market expansion, or that any anticipated business objectives, strategic initiatives, partnerships or growth opportunities will be realized. Actual results may differ materially from those currently anticipated in such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and are based on the beliefs, estimates, expectations and opinions of management on the date such statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8814b7b4-4011-4068-9441-88f557ab5f3e

Canadian clearance supports site activation and enrollment in the global study of once-daily oral PALI-2108

Primary efficacy results from approximately 204 patients with moderately to severely active ulcerative colitis expected in the second half of 2027

Denver, CO, Sept. 23, 2026 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation prodrugs for patients living with inflammatory and fibrotic diseases, today announced that Health Canada has cleared the Company’s Clinical Trial Application (CTA) for ASCENTRA-UC, its global Phase 2 study evaluating PALI-2108 in patients with moderately to severely active ulcerative colitis (UC).

The clearance enables Palisade to advance clinical trial activities in Canada, expanding the study’s geographic reach and supporting planned enrollment. Together with prior regulatory clearance in the United States, this milestone advances the Company’s global site activation and enrollment strategy. Primary efficacy results from the study’s 12-week induction period are expected in the second half of 2027.

“Health Canada clearance represents another important execution milestone as we advance ASCENTRA-UC globally,” said JD Finley, Chief Executive Officer of Palisade Bio. “Our focus is on efficiently activating sites, expanding patient access to the study and delivering the clinical data needed to define PALI-2108’s potential in ulcerative colitis. We remain on track to begin patient dosing in the second half of 2026, with primary efficacy results expected in the second half of 2027.”

ASCENTRA-UC is a global, multicenter, randomized, double-blind, placebo-controlled, dose-ranging Phase 2 trial designed to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of PALI-2108 in patients with moderately to severely active UC. The study is expected to enroll approximately 204 patients and will evaluate once-daily 15 mg and 30 mg doses of PALI-2108 compared with placebo.

The primary endpoint is clinical remission at Week 12, as measured by the modified Mayo Score. Key secondary endpoints include clinical response, endoscopic improvement and histologic-endoscopic mucosal improvement. The study also includes a 36-week maintenance phase extension designed to evaluate durability of response and longer-term safety through Week 48.

“PALI-2108 is designed to combine the convenience of once-daily oral dosing with targeted activation in the terminal ileum and colon,” said Mitch Jones, M.D., Ph.D., President and Chief Medical Officer of Palisade Bio. “ASCENTRA-UC builds on the clinical and pharmacologic findings observed to date and will rigorously evaluate whether this approach can translate into clinical remission and mucosal improvement. Expanding the study into Canada supports enrollment and brings us closer to answering these important clinical questions.”

About PALI-2108

PALI-2108 is a once-daily oral PDE4 inhibitor prodrug designed for targeted activation in the terminal ileum and colon. Across Phase 1 studies in healthy volunteers and patients with ulcerative colitis and fibrostenotic Crohn’s disease, PALI-2108 demonstrated favorable safety and tolerability, differentiated pharmacokinetics and sustained PDE4 inhibition above IC90, supporting advancement into Phase 2 development.

About Palisade Bio

Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company developing prodrugs for patients living with inflammatory and fibrotic diseases.

The Company’s lead clinical product candidate, PALI-2108, is being advanced into Phase 2 clinical trials as a treatment for patients living with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). Despite the availability of multiple biologic and small-molecule therapies, many patients with UC and CD do not achieve durable remission, lose response over time, or discontinue treatment because of safety or tolerability limitations. The Company believes PALI-2108 has the potential to address these limitations through once-daily oral dosing, targeted lower-intestinal bioactivation and broad PDE4-mediated anti-inflammatory activity.

For more information, please go to www.palisadebio.com.

Forward Looking Statements

Any statements contained in this communication that are not statements of historical fact may be deemed to be forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include but are not limited to: implied or express statements regarding the pharmacological properties, safety, tolerability, clinical response and efficacy, and therapeutic potential of PALI-2108, dosing levels and timing of key PALI-2108 development milestones such as regulatory submissions and approvals, trial enrollments and commencements and efficacy readouts, and the Company’s expected cash runway. These forward-looking statements are based on the Company’s current expectations. Forward-looking statements involve risks and uncertainties. Important factors that could cause actual results to differ materially from those reflected in the Company’s forward-looking statements include, among others, the timing of enrollment, commencement and completion of the Company’s clinical trials; the Company’s reliance on PALI-2108, and its early stage of clinical development; the risk that prior results, such as signals of safety, clinical response and efficacy, dosing or durability of effect, observed from preclinical or clinical trials with a limited number of patients, will not be replicated or will not continue in ongoing or future studies or clinical trials involving the Company’s product candidates in clinical trials focused on the same or different indications; and other factors that are described in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2026, and the Quarterly Reports on Form 10-Q or other SEC filings that are filed thereafter. Investors are cautioned not to put undue reliance on these forward-looking statements. These forward-looking statements speak only as of the date hereof, and the Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based, except as required by law.

Investor Relations Contact
JTC Team, LLC
Jenene Thomas
908-824-0775
PALI@jtcir.com

Company Advances Development of First U.S. AI Infrastructure Hub,
Executes Its Quantum & AI Systems Strategy

ITASCA, Ill., Sept. 23, 2026 (GLOBE NEWSWIRE) — Quanome Technologies, Inc. (Nasdaq: QNME) (“Quanome” or the “Company”) is advancing its Quantum and AI Systems business through an approximately US$18.8 million purchase agreement for computing infrastructure powered by NVIDIA GPU technology to build its AI cloud business through its subsidiary, XDT Infrastructure I, LLC (“XDT”). The Company entered into the agreement on September 16, 2026, representing an initial step in executing Quanome’s strategy and its planned phased development of XDT.

Through XDT, Quanome aims to give businesses managed access to AI computing capacity to support their development and expansion. Once operational, clients will be able to develop and run AI applications, process complex data and scale their computing capacity without building and managing their own infrastructure. These capabilities are designed to support faster product development, automation and improved business productivity. For Quanome, XDT offers the potential to build recurring revenue from computing services, with further investment intended to align with customer demand, available funding and operational readiness.

Demand for AI computing services is expanding as businesses integrate AI into their operations. The U.S. Census Bureau reported that 17% to 20% of U.S. businesses used AI between December 2025 and May 2026, while 20% to 23% expected to use it in the following six months. This adoption trend reinforces the importance of scalable computing capacity for businesses seeking to develop and deploy AI applications.

Yang Li, Chief Executive Officer of Quanome Technologies, said: “This investment puts Quanome’s commitment to quantum and AI into action. Through XDT, we aim to give more businesses access to advanced AI computing to power their growth. Our priorities are clear: launch our first hub, grow a strong client base and build recurring revenue to deliver long-term shareholder value.”

XDT sits within Quanome’s Quantum and AI Systems strategic stream, alongside the Group’s three other areas of focus: Quantum Life Sciences – Molecular Discovery, Advanced Nuclear, and Quantum-Safe Cybersecurity. It supports Quanome’s broader objective of translating scientific and technological advances into practical applications that enhance industrial productivity and support economic development.

Quanome expects its first U.S. AI infrastructure hub to be operational from Q4 2026, subject to delivery and deployment.

ENDS

Media / Investor Contact
investor@quanometech.com
www.quanometech.com / www.xdt.com

Editors Notes

About Quanome Technologies

Quanome Technologies, Inc. (Nasdaq: QNME) focuses on opportunities across Quantum and AI Systems, Quantum Life Sciences – Molecular Discovery, Advanced Nuclear, and Quantum-Safe Cybersecurity. The Company combines commercial initiatives with the development of a global scientific network through its Global Quantum Council and Scientific Advisory Network. Through its subsidiary “XDT” (XDT Infrastructure I, LLC), Quanome is building an AI cloud business to broaden access to advanced computing resources. www.quanometech.com / www.xdt.com

Forward-Looking Statements

This release contains forward-looking statements regarding the purchase, delivery, deployment and utilization of GPU servers; the expected commencement of operations in Q4 2026; the development and expansion of XDT; and anticipated customer benefits and revenue opportunities. These statements are based on current plans, assumptions and expectations and involve risks and uncertainties. Actual results and timing may differ materially due to financing availability, customer demand, supplier performance, production and delivery conditions, regulatory requirements, technical and operational matters, third-party performance and other transaction conditions. There can be no assurance that the purchase or deployment will be completed as contemplated, that operations will begin on the expected schedule, or that the intended commercial benefits will be achieved. Additional risks are described in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements except as required by applicable law.

Allowance extends the Company’s patent family covering gesture and proportional-control interaction with digital devices, from consumer electronics and XR to emerging applications in robotics and physical AI

YOKNEAM ILLIT, ISRAEL, Sept. 23, 2026 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced a Notice of Allowance from the China National Intellectual Property Administration (“CNIPA”) for its patent application.

The allowed application, titled “Method and Apparatus for a Gesture Controlled Interface for Wearable Devices,” extends a U.S.-granted intellectual property (“IP”) family covering a wrist-worn band that senses surface nerve conduction signals, the Company’s term for surface electromyography (“EMG”)-class bio-potentials, and turns hand and finger movement into commands without cameras, controllers or touchscreens. The China allowance specifically protects the Company’s technological ability to measure the intensity of a gesture – not just whether fingers were pressed together, but how firmly. This distinction converts a simple on/off motion into smooth, continuous, pressure-based control, much like a dimmer rather than a standard light switch.

The Company sees this capability supporting a broad set of applications across its target markets:

• Consumer electronics, extended reality (“XR”) products, and smart glasses – Intuitive, touchless micro-gesture control, navigation, and interaction with digital overlays from the wrist.
• Robotics and physical AI – An emerging area in which capturing the force and motion an individual applies may help robots learn physical tasks from human demonstration. Because the sensing takes place at the user’s wrist, an individual can be recorded working bare-handed and naturally, without instrumented gloves or force-sensing rigs that alter the way an object is handled.
• Accessibility and healthcare – Device control for users with limited mobility and objective measurements of grip strength and rehabilitation progress which can assist users in daily life as well as in clinics.

“Human intent is grounded in physiology – you can’t scrape it from the internet,” said Guy Wagner, Chief Scientific Officer and co-founder of Wearable Devices. “It lives in the body’s own signals: not just that someone picked something up, but how carefully they held it. That kind of nuance is what makes everyday device control feel natural, and it is also what newer fields such as physical AI will need as machines learn from people. We believe that securing this protection in China – the world’s largest developer, manufacturer and market for robotics and consumer electronics – is an important step for our IP portfolio.”

This allowance sits within a broader IP portfolio that now comprises 14 patent matters across the United States, China, and South Korea, six of which have been granted. With priority dates as early as 2015, this protection runs as late as 2043. Alongside its registered MUDRA trademark, the Company continues to pursue protection across major markets as part of a long-standing IP strategy supporting future licensing and partnership opportunities.

About Wearable Devices Ltd.

Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a growth company pioneering human-computer interaction through its AI-powered neural input touchless technology. Leveraging proprietary sensors, software, and advanced AI algorithms, the Company’s product offerings, including the Mudra Band, Mudra Link, and Mudra Pro, are defining the neural input category both for wrist-worn devices and for brain-computer interfaces. These products enable touch-free, intuitive control of digital devices using gestures across multiple operating systems.

Operating through a dual-channel model of direct-to-consumer sales and enterprise licensing and collaborations, Wearable Devices empowers consumers with stylish, functional wearables for enhanced experiences in gaming, productivity, and XR. In the business sector, the Company provides enterprise partners with advanced input solutions for immersive and interactive environments, from augmented reality/virtual reality/XR to smart environments. By setting the standard for neural input in the XR ecosystem, Wearable Devices is shaping the future of seamless, natural user experiences across some of the world’s fastest-growing tech markets. The ai6 Labs ecosystem accelerates this vision by integrating research, products, and AI breakthroughs. Expanding into Physical AI, the Company’s wearable neural sensing layer enriches human-generated training data for robotics and advanced physical systems.

Wearable Devices’ ordinary shares and warrants trade on the Nasdaq Capital Market under the symbols “WLDS” and “WLDSW,” respectively.

Forward-Looking Statements Disclaimer

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. For example, we are using forward-looking statements when we discuss the expected benefits of the allowed patent application, the potential applications of the Company’s technology, that the patent allowance marks an important step in the Company’s IP portfolio, and the Company’s future growth and market opportunities, including potential future licensing and partnership opportunities. All statements other than statements of historical facts included in this press release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the trading of our ordinary shares or warrants and the development of a liquid trading market; our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our annual report on Form 20-F for the year ended December 31, 2025, filed on March 12, 2026 and our other filings with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Investor Relations Contact:

Michal Efraty
IR@wearabledevices.co.il